We are live on ! Find out more
EOJOAM

E. Ohman J:or Asset Management Portfolio holdings

AUM $4.3B
1-Year Est. Return 29.55%
This Fund
S&P 500
This Quarter Est. Return
+22.53%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$4.3B
AUM Growth
+$519M
Cap. Flow
-$26.3M
Cap. Flow %
-0.61%
Top 10 Hldgs %
43.48%
Holding
487
New
10
Increased
143
Reduced
81
Closed
22

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$38.6M
2
SYK icon
Stryker
SYK
+$37.7M
3
COF icon
Capital One
COF
+$33.6M
4
DOV icon
Dover
DOV
+$31M
5
RDNT icon
RadNet
RDNT
+$23.4M

Top Sells

Rank Stock Value
1
CBOE icon
Cboe Global Markets
CBOE
+$56.7M
2
GILD icon
Gilead Sciences
GILD
+$44.4M
3
T icon
AT&T
T
+$34.8M
4
INTU icon
Intuit
INTU
+$32.5M
5
BSX icon
Boston Scientific
BSX
+$29.4M

Sector Composition

Rank Sector Weight
1 Technology 43.83%
2 Financials 13.15%
3 Healthcare 10.01%
4 Communication Services 9.79%
5 Consumer Discretionary 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOW icon
101
Lowe's Companies
LOW
$117B
$4.86M 0.11%
22,027
– –
PFE icon
102
Pfizer
PFE
$159B
$4.79M 0.11%
199,117
– –
CDNS icon
103
Cadence Design Systems
CDNS
$93.7B
$4.72M 0.11%
12,576
+450
+4% +$158K
TJX icon
104
TJX Companies
TJX
$149B
$4.65M 0.11%
30,680
-13,050
-30% -$2.06M
DELL icon
105
Dell
DELL
$295B
$4.44M 0.1%
10,300
-500
-5% -$145K
VRTX icon
106
Vertex Pharmaceuticals
VRTX
$137B
$4.38M 0.1%
8,823
– –
APP icon
107
Applovin
APP
$106B
$4.3M 0.1%
8,341
+2,750
+49% +$1.33M
DHR icon
108
Danaher
DHR
$152B
$4.24M 0.1%
22,273
– –
DNLI icon
109
Denali Therapeutics
DNLI
$3.84B
$4.12M 0.1%
+160,000
New +$3.29M
LNTH icon
110
Lantheus
LNTH
$6.58B
$4.1M 0.1%
36,937
– –
CRUS icon
111
Cirrus Logic
CRUS
$5.44B
$4.09M 0.1%
27,553
+1,341
+5% +$219K
SPGI icon
112
S&P Global
SPGI
$131B
$4.04M 0.09%
10,476
-3,300
-24% -$1.39M
LOB icon
113
Live Oak Bancshares
LOB
$1.86B
$4.03M 0.09%
98,745
– –
BMY icon
114
Bristol-Myers Squibb
BMY
$136B
$4.01M 0.09%
69,612
– –
RGEN icon
115
Repligen
RGEN
$9.95B
$3.9M 0.09%
28,600
– –
CMCSA icon
116
Comcast
CMCSA
$96B
$3.86M 0.09%
157,351
+3,000
+2% +$77.4K
SCHW
117
Charles Schwab
SCHW
$191B
$3.85M 0.09%
41,700
+2,000
+5% +$182K
HWM icon
118
Howmet Aerospace
HWM
$106B
$3.8M 0.09%
14,152
+1,500
+12% +$385K
OCUL icon
119
Ocular Therapeutix
OCUL
$2.28B
$3.78M 0.09%
385,000
+85,000
+28% +$770K
CAVA icon
120
CAVA Group
CAVA
$7.82B
$3.72M 0.09%
47,370
+6,281
+15% +$527K
FUTU icon
121
Futu Holdings
FUTU
$17.4B
$3.69M 0.09%
39,400
+36,000
+1,059% +$4.61M
SBUX icon
122
Starbucks
SBUX
$123B
$3.69M 0.09%
36,114
+5,400
+18% +$544K
VERA icon
123
Vera Therapeutics
VERA
$2.46B
$3.68M 0.09%
85,777
+42,787
+100% +$1.59M
PWR icon
124
Quanta Services
PWR
$90.6B
$3.65M 0.08%
5,070
– –
IBP icon
125
Installed Building Products
IBP
$6.53B
$3.61M 0.08%
15,711
+3,365
+27% +$818K
3 4
5
6 7

Similar funds

AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.3B AUM 24.01% 1-Year Est. Return
GHC
Great Hill Capital New York $4.29B AUM 18.17% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
DWM
Destination Wealth Management Walnut Creek, California $4.28B AUM 19.27% 1-Year Est. Return
HCC
Hill City Capital Boston, Massachusetts $4.28B AUM 80.76% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $4.28B AUM 43.07% 1-Year Est. Return

E. Ohman J:or Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, E. Ohman J:or Asset Management held 487 positions worth $4.3B, up 14% from $3.78B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

E. Ohman J:or Asset Management's Q2 2026 filing shows 10 new, 143 increased, 81 reduced and 22 closed positions. Its largest new stake was Denali Therapeutics: 160,000 shares worth $4.12M. The largest sale was Cboe Global Markets, an estimated $56.7M.

By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 42% a quarter earlier, followed by Financials and Healthcare.

  • E. Ohman J:or Asset Management's largest Q2 2026 buy was Denali Therapeutics: 160,000 shares worth $4.12M.
  • E. Ohman J:or Asset Management added most to Eli Lilly in Q2 2026, an estimated $38.6M increase.
  • E. Ohman J:or Asset Management's biggest Q2 2026 reduction was Cboe Global Markets, cutting an estimated $56.7M.
  • E. Ohman J:or Asset Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $1.17M.
  • E. Ohman J:or Asset Management's ten largest holdings make up 43% of its $4.3B portfolio in Q2 2026.
  • E. Ohman J:or Asset Management opened 10 new positions and closed 22 in Q2 2026.
  • E. Ohman J:or Asset Management's portfolio value rose 14% quarter-over-quarter to $4.3B.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.